Dupuy Gaël, Cavalcanti Lia, Bourgogne Emmanuel, Brichant-Petitjean Clara, Gomberoff Léon, Bloch Vanessa, Bellivier Frank, Lépine Jean-Pierre, Laprévote Olivier, Vorspan Florence
Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Psychiatrie, Hôpital Fernand-Widal, 200, rue du Faubourg St-Denis, Paris 75010, France.
Harm Reduct J. 2014 Jul 2;11:20. doi: 10.1186/1477-7517-11-20.
Methadone maintenance treatment is the most widely prescribed treatment for opiate dependence with proven benefits for patients. In naïve users or in case of recreational misuse, methadone can be a source of potentially lethal intoxications, resulting in fatal overdoses. A few cases of infantile intoxications have been described in the literature, some of which resulted in death. Nowadays, more than 50,000 bottles are used every day in France, most of which are thrown away in the bin. Relatives at home, especially children, can have access to these empty bottles. This study aims to determine whether the residual quantity of methadone in the bottles is associated with a risk of intoxication for someone who has a low tolerance to opiates, such as a child.
The methadone dosage left in a sample of 175 bottles recapped after use by the patients taking their maintenance treatment in an addiction treatment program centre was analysed during a 2-week period in March 2013.
The mean residual quantity of methadone left in each bottle after use is 1.9 ± 1.8 mg and 3.3 ± 2.4 mg in the sample of 60 mg bottles.
There is a potential danger of accidental overdose with empty bottles of methadone syrup, especially for children. To take into account this hazard, several harm reduction strategies can be proposed, such as favouring the taking of the treatment within the delivery centres rather than the 'take home' doses, asking methadone users to bring back their used bottles, and raising patients' awareness of the intoxication risks and the necessary everyday precautions. For stable patients with take home methadone, the use of capsules could be considered.
美沙酮维持治疗是治疗阿片类药物依赖最广泛使用的方法,已证实对患者有益。在初次使用者或娱乐性滥用的情况下,美沙酮可能是潜在致命中毒的来源,会导致致命的过量用药。文献中描述了几例婴儿中毒的病例,其中一些导致了死亡。如今,法国每天使用超过50,000瓶美沙酮,其中大部分被扔进垃圾桶。家中的亲属,尤其是儿童,可能会接触到这些空瓶。本研究旨在确定瓶中美沙酮的残留量是否与对阿片类药物耐受性低的人(如儿童)中毒风险相关。
2013年3月的两周内,对在一家成瘾治疗项目中心接受维持治疗的患者使用后重新封装的175个瓶子样本中的美沙酮剂量进行了分析。
使用后每个瓶子中美沙酮的平均残留量在60毫克装的瓶子样本中为1.9±1.8毫克,在另一样本中为3.3±2.4毫克。
美沙酮糖浆空瓶存在意外过量用药的潜在危险,尤其是对儿童。为考虑到这一危害,可以提出几种减少伤害的策略,例如鼓励在给药中心内服药而非“带回家”剂量,要求美沙酮使用者带回用过的瓶子,并提高患者对中毒风险和日常必要预防措施的认识。对于稳定的可带回家服用美沙酮的患者,可以考虑使用胶囊。